Vir Biotechnology Gross Margin Growth & History (VIR)
Vir Biotechnology's gross margin was 99.96% for fiscal 2025.
View full Vir Biotechnology company overviewVir Biotechnology annual gross margin history
2019
2020
2021
2022
2023
2024
2025
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 99.96% | +1.10 pp |
| 2024 | 2024-12-31 | 98.86% | +2.07 pp |
| 2023 | 2023-12-31 | 96.79% | +5.85 pp |
| 2022 | 2022-12-31 | 90.94% | −3.04 pp |
| 2021 | 2021-12-31 | 93.99% | −6.01 pp |
| 2020 | 2020-12-31 | 100.00% | 0.00 pp |
| 2019 | 2019-12-31 | 100.00% | — |
Vir Biotechnology quarterly gross margin
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q2.26
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 100.00% | +0.91 pp |
| Q4 2025 | 2025-12-31 | 99.48% | +5.00 pp |
| Q3 2025 | 2025-09-30 | −22.50% | −120.40 pp |
| Q2 2025 | 2025-06-30 | 99.09% | +0.78 pp |
| Q1 2025 | 2025-03-31 | 100.00% | +0.10 pp |
| Q4 2024 | 2024-12-31 | 94.47% | −0.77 pp |
| Q3 2024 | 2024-09-30 | 97.90% | −0.66 pp |
| Q2 2024 | 2024-06-30 | 98.31% | −1.11 pp |
| Q1 2024 | 2024-03-31 | 99.90% | +2.92 pp |
| Q4 2023 | 2023-12-31 | 95.25% | +7.38 pp |
| Q3 2023 | 2023-09-30 | 98.56% | +4.50 pp |
| Q2 2023 | 2023-06-30 | 99.42% | — |
| Q1 2023 | 2023-03-31 | 96.97% | +4.29 pp |
| Q4 2022 | 2022-12-31 | 87.86% | −5.14 pp |
| Q3 2022 | 2022-09-30 | 94.06% | +1.62 pp |
| Q1 2022 | 2022-03-31 | 92.69% | −7.31 pp |
| Q4 2021 | 2021-12-31 | 93.00% | — |
| Q3 2021 | 2021-09-30 | 92.44% | −7.56 pp |
| Q2 2021 | 2021-06-30 | 99.35% | −0.65 pp |
| Q1 2021 | 2021-03-31 | 100.00% | — |
| Q3 2020 | 2020-09-30 | 100.00% | — |
| Q2 2020 | 2020-06-30 | 100.00% | — |
Vir Biotechnology gross margin trends
Over the last five fiscal years, Vir Biotechnology's gross margin decreased from 100.00% to 99.96%, a change of −0.04 percentage points. The latest reported quarter, Q2 2026, shows 100.00%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Vir Biotechnology source filings ↗